GO Main Menu Go Main Contents Go Bottom Menu
  • Yuflyma® image
    • Product Name : Yuflyma®
    • INN : adalimumab
    • Indications : Rheumatoid arthritis, Axial spondyloarthritis, Psoriasis, Psoriatic arthritis, Crohn’s disease, Hidradenitis suppurativa, Ulcerative colitis, Uveitis, Paediatric plaque psoriasis, paediatric Crohn’s disease, paediatric ulcerative colitis, paediatric uveit
    • Protein Type : Monoclonal antibody (mAb)
    • Mechanism of Action : Specifically targets and blocks TNF-alpha which contributes to the inflammation.
    • Drug Approval Status : EU (2021-02-11)

    This product description is for medical and educational purposes only.
    They are not intended to promote PR or sales campaigns.
    For more details, please consult a doctor or a medical specialist. This site is intended for all over the world.